Annual Operating Margin
-16.04 K%
-13.43 K%-515.06%
31 December 2023
Summary:
Inovio Pharmaceuticals annual operating profit margin is currently -16.04 thousand%, with the most recent change of -13.43 thousand% (-515.06%) on 31 December 2023. During the last 3 years, it has fallen by -14.36 thousand% (-857.84%). INO annual operating margin is now -19300.76% below its all-time high of -82.66%, reached on 31 March 1999.INO Operating Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Margin
N/A
30 September 2024
Summary:
Inovio Pharmaceuticals quarterly operating profit margin is not available.INO Quarterly Operating Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
INO Operating Margin Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -515.1% | - |
3 y3 years | -857.8% | - |
5 y5 years | -5095.2% | - |
INO Operating Margin High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -857.8% | +5.5% | ||
5 y | 5 years | -5095.2% | +5.5% | ||
alltime | all time | <-9999.0% | +5.5% |
Inovio Pharmaceuticals Operating Margin History
Date | Annual | Quarterly |
---|---|---|
June 2024 | - | -32.95 K%(+23.5%) |
Dec 2023 | -16.04 K%(+515.1%) | -26.69 K%(+314.0%) |
Sept 2023 | - | -6446.11%(-60.7%) |
June 2023 | - | -16.39 K%(-57.1%) |
Mar 2023 | - | -38.24 K%(-14.8%) |
Dec 2022 | -2607.35%(-84.6%) | -44.88 K%(>+9900.0%) |
Sept 2022 | - | -390.61%(-97.1%) |
June 2022 | - | -13.28 K%(-63.2%) |
Mar 2022 | - | -36.03 K%(+186.6%) |
Dec 2021 | -16.97 K%(+913.7%) | -12.57 K%(-38.8%) |
Sept 2021 | - | -20.55 K%(-32.6%) |
June 2021 | - | -30.50 K%(+115.4%) |
Mar 2021 | - | -14.16 K%(+2593.5%) |
Dec 2020 | -1674.25%(-38.0%) | -525.74%(-96.6%) |
Sept 2020 | - | -15.38 K%(+23.9%) |
June 2020 | - | -12.42 K%(+553.2%) |
Mar 2020 | - | -1901.06%(-82.5%) |
Dec 2019 | -2702.10%(+775.4%) | -10.88 K%(+293.9%) |
Sept 2019 | - | -2763.04%(-86.7%) |
June 2019 | - | -20.79 K%(+1961.4%) |
Mar 2019 | - | -1008.34%(-14.5%) |
Dec 2018 | -308.68%(+54.0%) | -1178.73%(-11.5%) |
Sept 2018 | - | -1331.56%(+6157.3%) |
June 2018 | - | -21.28%(-99.0%) |
Mar 2018 | - | -2140.77%(+687.5%) |
Dec 2017 | -200.48%(-8.2%) | -271.85%(-75.4%) |
Sept 2017 | - | -1103.61%(+2237.7%) |
June 2017 | - | -47.21%(-77.7%) |
Mar 2017 | - | -211.39%(-19.5%) |
Dec 2016 | -218.38%(+151.1%) | -262.67%(+63.1%) |
Sept 2016 | - | -161.04%(-48.0%) |
June 2016 | - | -309.92%(+62.7%) |
Mar 2016 | - | -190.51%(-22.2%) |
Dec 2015 | -86.97%(-77.0%) | -244.74%(-1686.1%) |
Sept 2015 | - | 15.43%(-105.1%) |
June 2015 | - | -304.92%(+88.3%) |
Mar 2015 | - | -161.95%(-63.9%) |
Dec 2014 | -377.71%(+136.1%) | -448.16%(-1.0%) |
Sept 2014 | - | -452.69%(+69.5%) |
June 2014 | - | -267.07%(-37.0%) |
Mar 2014 | - | -424.15%(-18.0%) |
Dec 2013 | -159.97%(-73.3%) | -517.56%(-6513.4%) |
Sept 2013 | - | 8.07%(-101.0%) |
June 2013 | - | -849.28%(+86.3%) |
Mar 2013 | - | -455.88%(-16.9%) |
Dec 2012 | -598.36%(+163.7%) | -548.76%(-30.9%) |
Sept 2012 | - | -794.67%(-48.9%) |
June 2012 | - | -1556.57%(+444.8%) |
Mar 2012 | - | -285.72%(-19.3%) |
Dec 2011 | -226.90% | -354.00%(+39.9%) |
Sept 2011 | - | -253.02%(+19.2%) |
Date | Annual | Quarterly |
---|---|---|
June 2011 | - | -212.28%(+42.2%) |
Mar 2011 | - | -149.29%(-33.3%) |
Dec 2010 | -312.79%(+104.4%) | -223.75%(-37.3%) |
Sept 2010 | - | -356.94%(-18.6%) |
June 2010 | - | -438.47%(+36.6%) |
Mar 2010 | - | -320.91%(+120.0%) |
Dec 2009 | -153.04%(-76.5%) | -145.85%(+47.9%) |
Sept 2009 | - | -98.63%(-17.8%) |
June 2009 | - | -120.02%(-87.5%) |
Mar 2009 | - | -963.71%(-9.0%) |
Dec 2008 | -651.14%(+96.9%) | -1059.09%(+75.2%) |
Sept 2008 | - | -604.43%(-2.3%) |
June 2008 | - | -618.73%(+20.8%) |
Mar 2008 | - | -512.37%(+839.6%) |
Dec 2007 | -330.68%(-14.1%) | -54.53%(-94.7%) |
Sept 2007 | - | -1033.19%(+7.6%) |
June 2007 | - | -959.85%(+12.4%) |
Mar 2007 | - | -854.07%(+244.8%) |
Dec 2006 | -384.82%(+72.8%) | -247.69%(-59.7%) |
Sept 2006 | - | -614.20%(+27.1%) |
June 2006 | - | -483.29%(+19.9%) |
Mar 2006 | - | -403.01%(+8.9%) |
Dec 2005 | -222.69%(-77.4%) | -369.95%(-11.6%) |
Sept 2005 | - | -418.69%(+465.5%) |
June 2005 | - | -74.04%(-81.7%) |
Mar 2005 | - | -404.26%(-43.6%) |
Dec 2004 | -986.27%(-88.0%) | -716.16%(-8.0%) |
Sept 2004 | - | -778.18%(-68.5%) |
June 2004 | - | -2469.66%(+6.0%) |
Mar 2004 | - | -2330.00%(-50.9%) |
Dec 2003 | -8237.11%(+163.0%) | -4748.19%(-37.6%) |
Sept 2003 | - | -7608.09%(-51.1%) |
June 2003 | - | -15.55 K%(-0.8%) |
Mar 2003 | - | -15.67 K%(+727.9%) |
Dec 2002 | -3131.53%(-41.7%) | -1892.76%(-12.7%) |
Sept 2002 | - | -2168.57%(-41.7%) |
June 2002 | - | -3717.74%(-88.9%) |
Mar 2002 | - | -33.41 K%(>+9900.0%) |
Dec 2001 | -5368.16%(+4252.7%) | - |
Sept 2001 | - | -131.22%(-59.9%) |
June 2001 | - | -326.94%(+71.7%) |
Mar 2001 | -123.33%(-34.3%) | - |
Dec 2000 | - | -190.41%(+47.8%) |
Sept 2000 | - | -128.80%(-18.9%) |
June 2000 | - | -158.78%(-7.5%) |
Mar 2000 | -187.79%(+127.2%) | -171.57%(+8.4%) |
Dec 1999 | - | -158.33%(+18.8%) |
Sept 1999 | - | -133.33%(-60.0%) |
June 1999 | - | -333.33%(-1395.0%) |
Mar 1999 | -82.66% | 25.74%(-107.2%) |
Dec 1998 | - | -355.56% |
FAQ
- What is Inovio Pharmaceuticals annual operating profit margin?
- What is the all time high annual operating margin for Inovio Pharmaceuticals?
- What is Inovio Pharmaceuticals annual operating margin year-on-year change?
- What is the all time high quarterly operating margin for Inovio Pharmaceuticals?
What is Inovio Pharmaceuticals annual operating profit margin?
The current annual operating margin of INO is -16.04 K%
What is the all time high annual operating margin for Inovio Pharmaceuticals?
Inovio Pharmaceuticals all-time high annual operating profit margin is -82.66%
What is Inovio Pharmaceuticals annual operating margin year-on-year change?
Over the past year, INO annual operating profit margin has changed by -13.43 K% (-515.06%)
What is the all time high quarterly operating margin for Inovio Pharmaceuticals?
Inovio Pharmaceuticals all-time high quarterly operating profit margin is 25.74%